Igeneon AG
Igeneon was a Vienna-based drug discovery company focused on cancer immunotherapy. In 2005, Igeneon was merged in an all-share-deal with the listed US-Biotech company Aphton. In 2006, Aphton filed for bankruptcy and was liquidated.
Igeneon was a Vienna-based drug discovery company focused on cancer immunotherapy. In 2005, Igeneon was merged in an all-share-deal with the listed US-Biotech company Aphton. In 2006, Aphton filed for bankruptcy and was liquidated.